Antibodies
11 June 2009
ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound10 June 2009
New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients8 June 2009
Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes8 June 2009
XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach to Type 2 Diabetes Treatment8 June 2009
Seattle Genetics Reports Data from SGN-35 Every Three Week Dosing Phase I Trial in Lymphoma5 June 2009
Immunomedics Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura2 June 2009
CuraGen Updates CR011-vcMMAE Data at ASCO1 June 2009
Seattle Genetics Reports Data from a Weekly Dosing Phase I Clinical Trial of SGN-35 in LymphomaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports